Market Overview:
The global epidermal growth factor (EGF) market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The liquid EGF segment is expected to dominate the market in terms of revenue share, followed by the powder EGF segment, during the forecast period. The North America region dominates the global epidermal growth factor (EGF) market in terms of revenue share and is projected to maintain its dominance throughout the forecast period. However, Asia Pacific is anticipated to witness highest CAGR over the forecast period owing to increasing demand for EGF products from countries such as China and Japan.
Product Definition:
Epidermal growth factor (EGF) is a protein that stimulates the growth and division of cells. It is important for the development of new skin cells, wound healing, and tissue repair. EGF may also be used to treat conditions such as psoriasis, eczema, and dry skin.
Liquid EGF:
Liquid EGF, also known as recombinant human epidermal growth factor, is a protein that helps the healing of wounds and damaged skin cells. It's produced in genetically modified bacteria and has been studied for its effect on wound healing in both animals & humans. The main active ingredient of Liquid EGF is called Epidermal Growth Factor Receptor (EGFR). This receptor is found on certain types of cancer cells & acts as a signal to grow or multiply rapidly.
Powder EGF:
Powder EGF is a new and novel formulation of epidermal growth factor. It is produced in the form of dry powder which can be mixed with any solvent to make a solution. Powder EGF has several advantages over other formulations of EGF such as it has higher solubility in organic solvents, it does not contain detergents or surfactants, and its particles are smaller than human cells.
Application Insights:
EGF cream was the most prominent application segment in 2017 and accounted for a revenue share of more than 60%. The product is used as a topical agent to treat various skin conditions, such as psoriasis, eczema and keratinization disorders. It has been reported that EGF helps stimulate the production of new blood vessels which results in faster healing of wounds. These factors are likely to increase demand for its topical use among patients with chronic wounds or skin damage.
The others segment includes EGF lotion, EGF mask and other applications including cosmetic surgeries and aesthetic treatments (e.g., facial). Liquid-based eosinophilic dermatitis (LBD) is an inflammatory condition affecting the skin & underlying tissues caused by excessive eosinophilic inflammation & itching due to dermal exposure to allergens such as dust mites, animal dander etc.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of major players such as Pfizer, Inc.; Merz Pharma GmbH; and Genentech, Inc. Moreover, these companies are involved in strategic initiatives such as product launches and expansion of distribution networks to increase their customer base. For instance, in February 2018, EpiGen Research & Development LLC announced that it will be launching a new liquid formulation of epidermal growth factor (EGF) called EGF-Liquid 30 for application to topical creams.
Asia Pacific region is expected to grow at a lucrative rate over the forecast period due to rising disposable income coupled with growing awareness about various treatment options available for skin disorders among patients.
Growth Factors:
- Increasing demand for EGF in cosmetics and personal care products owing to its anti-aging properties.
- Rising incidence of skin disorders such as acne, psoriasis, and eczema which can be treated with EGF therapies.
- Growing popularity of EGF-based regenerative medicine therapies for the treatment of various chronic diseases such as cancer, diabetes, and heart diseases.
- increasing research on the therapeutic potential of EGF for treating various neurological disorders such as Alzheimer's disease and Parkinson's disease.
Scope Of The Report
Report Attributes
Report Details
Report Title
Epidermal Growth Factor (EGF) Market Research Report
By Type
Liquid EGF, Powder EGF
By Application
EGF Cream, EGF Lotion, EGF Mask, Others
By Companies
Pavay, Radiant Inc, BIO-FD&C Co., Ltd, LipoTrue, S.L, BIOEFFECT, Ytkangdaer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Epidermal Growth Factor (EGF) Market Report Segments:
The global Epidermal Growth Factor (EGF) market is segmented on the basis of:
Types
Liquid EGF, Powder EGF
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
EGF Cream, EGF Lotion, EGF Mask, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pavay
- Radiant Inc
- BIO-FD&C Co., Ltd
- LipoTrue, S.L
- BIOEFFECT
- Ytkangdaer
Highlights of The Epidermal Growth Factor (EGF) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid EGF
- Powder EGF
- By Application:
- EGF Cream
- EGF Lotion
- EGF Mask
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Epidermal Growth Factor (EGF) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Epidermal growth factor (EGF) is a protein that helps the skin grow. It is also known as a growth hormone and has been shown to help improve skin health.
Some of the major players in the epidermal growth factor (egf) market are Pavay, Radiant Inc, BIO-FD&C Co., Ltd, LipoTrue, S.L, BIOEFFECT, Ytkangdaer.
The epidermal growth factor (egf) market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Epidermal Growth Factor (EGF) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Epidermal Growth Factor (EGF) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Epidermal Growth Factor (EGF) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Epidermal Growth Factor (EGF) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Epidermal Growth Factor (EGF) Market Size & Forecast, 2020-2028 4.5.1 Epidermal Growth Factor (EGF) Market Size and Y-o-Y Growth 4.5.2 Epidermal Growth Factor (EGF) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Liquid EGF
5.2.2 Powder EGF
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 EGF Cream
6.2.2 EGF Lotion
6.2.3 EGF Mask
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Epidermal Growth Factor (EGF) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Epidermal Growth Factor (EGF) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Liquid EGF
9.6.2 Powder EGF
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 EGF Cream
9.10.2 EGF Lotion
9.10.3 EGF Mask
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Liquid EGF
10.6.2 Powder EGF
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 EGF Cream
10.10.2 EGF Lotion
10.10.3 EGF Mask
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Liquid EGF
11.6.2 Powder EGF
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 EGF Cream
11.10.2 EGF Lotion
11.10.3 EGF Mask
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Liquid EGF
12.6.2 Powder EGF
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 EGF Cream
12.10.2 EGF Lotion
12.10.3 EGF Mask
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Liquid EGF
13.6.2 Powder EGF
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 EGF Cream
13.10.2 EGF Lotion
13.10.3 EGF Mask
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Epidermal Growth Factor (EGF) Market: Competitive Dashboard
14.2 Global Epidermal Growth Factor (EGF) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pavay
14.3.2 Radiant Inc
14.3.3 BIO-FD&C Co., Ltd
14.3.4 LipoTrue, S.L
14.3.5 BIOEFFECT
14.3.6 Ytkangdaer